Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022506351> ?p ?o ?g. }
- W2022506351 endingPage "1629" @default.
- W2022506351 startingPage "1619" @default.
- W2022506351 abstract "Patients receiving oral anticoagulation (OAC) who undergo drug-eluting stent (DES) implantation require additional dual antiplatelet therapy with aspirin and clopidogrel. Such triple therapy confers an elevated bleeding risk, and its optimal duration is not known. The goal of this study was to evaluate whether shortening the duration of clopidogrel therapy from 6 months to 6 weeks after DES implantation was associated with a superior net clinical outcome in patients receiving concomitant aspirin and OAC. In this randomized, open-label trial, we enrolled patients receiving OAC who underwent DES implantation at 3 European centers between September 2008 and December 2013. A total of 614 patients receiving concomitant aspirin and OAC were randomized to either 6-week clopidogrel therapy (n = 307) or 6-month clopidogrel therapy (n = 307). The primary endpoint was a composite of death, myocardial infarction (MI), definite stent thrombosis, stroke, or Thrombolysis In Myocardial Infarction (TIMI) major bleeding at 9 months. The primary endpoint occurred in 30 patients (9.8%) in the 6-week group compared with 27 patients (8.8%) in the 6-month group (hazard ratio [HR]: 1.14; 95% CI: 0.68 to 1.91; p = 0.63). There were no significant differences for the secondary combined ischemic endpoint of cardiac death, MI, definite stent thrombosis, and ischemic stroke (12 [4.0%] vs. 13 [4.3%]; HR: 0.93; 95% CI: 0.43 to 2.05; p = 0.87) or the secondary bleeding endpoint of TIMI major bleeding (16 [5.3%] vs. 12 [4.0%]; HR: 1.35; 95% CI: 0.64 to 2.84; p = 0.44). Six weeks of triple therapy was not superior to 6 months with respect to net clinical outcomes. These results suggest that physicians should weigh the trade-off between ischemic and bleeding risk when choosing the shorter or longer duration of triple therapy. (Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation [ISAR-TRIPLE]; NCT00776633)" @default.
- W2022506351 created "2016-06-24" @default.
- W2022506351 creator A5006952690 @default.
- W2022506351 creator A5007093669 @default.
- W2022506351 creator A5012755919 @default.
- W2022506351 creator A5013878625 @default.
- W2022506351 creator A5015044428 @default.
- W2022506351 creator A5015669756 @default.
- W2022506351 creator A5021595862 @default.
- W2022506351 creator A5023042885 @default.
- W2022506351 creator A5030010606 @default.
- W2022506351 creator A5041318172 @default.
- W2022506351 creator A5066812477 @default.
- W2022506351 creator A5069679013 @default.
- W2022506351 creator A5070212671 @default.
- W2022506351 creator A5072633257 @default.
- W2022506351 creator A5078073832 @default.
- W2022506351 creator A5086795617 @default.
- W2022506351 creator A5091776005 @default.
- W2022506351 date "2015-04-01" @default.
- W2022506351 modified "2023-10-14" @default.
- W2022506351 title "Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation" @default.
- W2022506351 cites W1421247184 @default.
- W2022506351 cites W146673325 @default.
- W2022506351 cites W1475865131 @default.
- W2022506351 cites W1965953472 @default.
- W2022506351 cites W1970781792 @default.
- W2022506351 cites W1993520864 @default.
- W2022506351 cites W2005421130 @default.
- W2022506351 cites W2041726140 @default.
- W2022506351 cites W2048216325 @default.
- W2022506351 cites W2081613030 @default.
- W2022506351 cites W2087150869 @default.
- W2022506351 cites W2101986337 @default.
- W2022506351 cites W2103798714 @default.
- W2022506351 cites W2108064339 @default.
- W2022506351 cites W2108659563 @default.
- W2022506351 cites W2116194566 @default.
- W2022506351 cites W2116274343 @default.
- W2022506351 cites W2116772666 @default.
- W2022506351 cites W2117559770 @default.
- W2022506351 cites W2117677020 @default.
- W2022506351 cites W2122779695 @default.
- W2022506351 cites W2125173296 @default.
- W2022506351 cites W2140501627 @default.
- W2022506351 cites W2150086052 @default.
- W2022506351 cites W2150914344 @default.
- W2022506351 cites W2156927593 @default.
- W2022506351 cites W2159193915 @default.
- W2022506351 cites W2159370853 @default.
- W2022506351 cites W2162446501 @default.
- W2022506351 cites W2165626532 @default.
- W2022506351 cites W2329490408 @default.
- W2022506351 cites W4205645630 @default.
- W2022506351 cites W4236531408 @default.
- W2022506351 doi "https://doi.org/10.1016/j.jacc.2015.02.050" @default.
- W2022506351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25908066" @default.
- W2022506351 hasPublicationYear "2015" @default.
- W2022506351 type Work @default.
- W2022506351 sameAs 2022506351 @default.
- W2022506351 citedByCount "375" @default.
- W2022506351 countsByYear W20225063512013 @default.
- W2022506351 countsByYear W20225063512015 @default.
- W2022506351 countsByYear W20225063512016 @default.
- W2022506351 countsByYear W20225063512017 @default.
- W2022506351 countsByYear W20225063512018 @default.
- W2022506351 countsByYear W20225063512019 @default.
- W2022506351 countsByYear W20225063512020 @default.
- W2022506351 countsByYear W20225063512021 @default.
- W2022506351 countsByYear W20225063512022 @default.
- W2022506351 countsByYear W20225063512023 @default.
- W2022506351 crossrefType "journal-article" @default.
- W2022506351 hasAuthorship W2022506351A5006952690 @default.
- W2022506351 hasAuthorship W2022506351A5007093669 @default.
- W2022506351 hasAuthorship W2022506351A5012755919 @default.
- W2022506351 hasAuthorship W2022506351A5013878625 @default.
- W2022506351 hasAuthorship W2022506351A5015044428 @default.
- W2022506351 hasAuthorship W2022506351A5015669756 @default.
- W2022506351 hasAuthorship W2022506351A5021595862 @default.
- W2022506351 hasAuthorship W2022506351A5023042885 @default.
- W2022506351 hasAuthorship W2022506351A5030010606 @default.
- W2022506351 hasAuthorship W2022506351A5041318172 @default.
- W2022506351 hasAuthorship W2022506351A5066812477 @default.
- W2022506351 hasAuthorship W2022506351A5069679013 @default.
- W2022506351 hasAuthorship W2022506351A5070212671 @default.
- W2022506351 hasAuthorship W2022506351A5072633257 @default.
- W2022506351 hasAuthorship W2022506351A5078073832 @default.
- W2022506351 hasAuthorship W2022506351A5086795617 @default.
- W2022506351 hasAuthorship W2022506351A5091776005 @default.
- W2022506351 hasBestOaLocation W20225063511 @default.
- W2022506351 hasConcept C126322002 @default.
- W2022506351 hasConcept C127413603 @default.
- W2022506351 hasConcept C141071460 @default.
- W2022506351 hasConcept C164705383 @default.
- W2022506351 hasConcept C168563851 @default.
- W2022506351 hasConcept C203092338 @default.
- W2022506351 hasConcept C207103383 @default.
- W2022506351 hasConcept C2777628954 @default.